Apr 01, 2022 13:13 JST

Source: Denso

Marubeni, OPExPARK, Beyond Next Ventures and DENSO Collaborate to Promote DX in the Healthcare Industry

TOKYO, Apr 01, 2022 - (JCN Newswire) - Marubeni Corporation ("Marubeni"), OPExPARK Inc. ("OPExPARK"), Beyond Next Ventures Inc. ("BNV") and DENSO CORPORATION ("DENSO") have agreed for Marubeni to invest with BNV andin OPExPARK to support the digital transformation ("DX") of operating rooms and a surgical education platform business for doctors ("this project"). OPExPARK was jointly established by DENSO and BNV.

From left, BNV Executive Officer Katsuya Hashizume, OPExPARK President and CEO Yasunori Honda, Marubeni Executive Officer Chief Operating Officer of the ICT & Real Estate Business Div. Tatsuya Abe, and DENSO Manager Hideki Okuda
 


In recent years, the need for DX has been rapidly increasing in the healthcare industry, as represented by the development of new medical services such as telemedicine and online medication guidance, and the utilization of medical data. In addition, with the decrease in the number of surgeries and restrictions on movement, delivering surgical education has been challenging, with young doctors having fewer opportunities to learn techniques from operations that senior doctors perform. Therefore, there is a growing expectation for an educational platform that allows doctors to learn surgical techniques online.

OPExPARK was established in 2019 with the support of BNV, utilizing the information integration platform "OPeLiNK" developed by DENSO with the support of the Japan Agency for Medical Research and Development. OPeLiNK is an information integration platform that constantly provides data gathered from each piece of equipment in the operating room, which is conventionally handled individually, with data in a consistent format so that it can be used by any device. By extracting and delivering accumulated equipment and biological data, information important to the decision-making of the surgeon can be visualized, and advanced tacit knowledge that was difficult to learn outside the operating room can be shared. OPExPARK promotes DX of surgical education through the delivery of educational contents that enables anyone to learn cutting-edge surgery anytime, anywhere. In addition, OPExPARK contributes to the improvement of the quality of medical care in Japan and overseas by transmitting surgical videos and data acquired by OPELiNK in real time and by providing advice on diagnosis and surgery from remote locations.

Marubeni has strengthened and expanded its IT consulting services business and cloud integration business to support and promote DX for customers and partners. By investing in this project and utilizing its cultivated know-how of DX support and promotion, support for IT fields (including the cloud), and cooperation with other businesses, Marubeni will contribute to the expansion of OPExPARK's services from DX in operating rooms and surgical education to DX in hospitals. By acquiring knowledge, networks, and business know-how in the healthcare industry through participation in this project, Marubeni aims to expand business in the digital health industry by promoting DX and developing new services in the field of drug discovery and clinical trial support in the future.

Since 2018, BNV has been involved in the establishment of OPExPARK (with carve-out support from DENSO) and support for its business growth. In establishing the company, BNV developed initial business strategies, business plans, and support for management team organization through "BRAVE", an acceleration program provided by BNV. After the company's establishment, BNV has been involved in continuous investment, recruitment, business development, and business growth support.

From 2014 to 2019, DENSO developed OPeLiNK and has been developing businesses that raise the medical level in emerging countries by utilizing the surgical information acquired through OPeLiNK. Even after OPExPARK's founding, DENSO has continued to acquire know-how in the digital twin business, support OPExPARK through joint research, and dispatch both technical and sales employees to the company.

Through this agreement and this project, Marubeni, OPExPARK, BNV, and DENSO will promote DX in the healthcare industry and contribute to the improvement of medical quality.

For more information, visit https://www.denso.com/global/en/.

Source: Denso
Sectors: MedTech

Copyright ©2023 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.

Related Press Release


DENSO Launches "Everycool," a Commercial Vehicle Cooling System for Trucks that Improves Cooling Efficiency and Reduces Environmental Impact
September 11 2023 18:19 JST
 
DENSO Announces Organization and Personnel Changes
September 01 2023 08:53 JST
 
DENSO to Exhibit at IAA Mobility 2023 in Munich
August 24 2023 17:28 JST
 
DENSO Sets Scope 3 as a New Target to Reduce Greenhouse Gas Emissions and Acquires SBT Certification
August 10 2023 10:21 JST
 
DENSO to Establish a New Office in Tokyo to Offer New Value in the Greater Tokyo Area
August 10 2023 09:00 JST
 
DENSO Acquires Full Stake in Certhon Group, a Greenhouse Provider Based in the Netherlands
August 01 2023 17:15 JST
 
DENSO Announces First Quarter Financial Results
July 28 2023 14:51 JST
 
DENSO Begins Business Transfer Negotiations for Selected Product Operations
July 10 2023 16:03 JST
 
TD Mobile, in which DENSO and Toyota Tsusho have invested, announcing transfer of cell phone sales and agency business to newly established subsidiary of ranet
July 10 2023 15:54 JST
 
DENSO to Begin SOEC Demonstration at Hirose Plant to Produce and Use Green Hydrogen for Manufacturing
June 27 2023 16:14 JST
 
More Press release >>

Latest Press Release


More Latest Release >>